Bavarian Nordic Launches Chikungunya Vaccine

The new chikungunya vaccine, recombinant (Vimkunya, Bavarian Nordic A/S), the first VLP single-dose, prefilled syringe vaccine approved by the FDA, is now available, the company announced.